The FreeStyle Libre 2 System
Minute-to-minute glucose readings sent to your patient's smartphone◊ to help them manage their diabetes more confidently4
Knowledge, Access, Resources, and Education – the four pillars that empower you to deliver better care:
Gain in-depth understanding of the FreeStyle Libre portfolio and the latest in glucose sensing technology.
Quickly find essential tools, prescribing guidance, and clinical insights.
Utilise practical resources to unlock valuable patient glucose reports, seamlessly integrated into your workflow.
Stay informed with best practices, clinical evidence, and educational materials tailored for you.
Provides key insights on several presentations from the Advanced Treatments and technology (ATTD) conference 2026, held in Barcelona.
Explores the pathophysiology of DKA and how diabetes technology can drive further reductions in the frequency and impact of DKA for people with diabetes.
Minute-to-minute glucose readings sent to your patient's smartphone◊ to help them manage their diabetes more confidently4
Your patients know sooner, can act faster and be ready to avoid hypos with our next-gen continuous glucose monitoring◊
Discover how you can get the most out of the FreeStyle Libre Portfolio with our Digital Health Solutions for both you and your patients
Our easy-to-use meters provide accurate results and reports for more meaningful insights
References & Disclaimers
Images are for illustrative purposes only. Not real patient, data, or healthcare professional.
* FreeStyle Libre systems refers to the FreeStyle Libre 2 and FreeStyle Libre 3 systems.
◊The FreeStyle Libre systems apps are only compatible with certain mobile devices and operating systems. Please check our website for more information about devicecompatibility before using the apps. Use of the FreeStyle Libre systems apps may require registration with LibreView.
4. Marion Fokkert, Peter van Dijk, Mireille Edens, Eglantine Barents, Jeanine Mollema, Robert Slingerland, Reinhold Gans, Henk Bilo. “Improved Well-Being and Decreased Disease Burden After 1-Year Use of Flash Glucose Monitoring (FLARE-NL4).” BMJ Open Diabetes Research & Care 7, e000809 (2019). https://doi.org/10.1136/bmjdrc-2019-000809.
6. Bolinder, J. Lancet (2016): https://doi.org/10.1016/S0140-6736(16)31535-5.
ADC-2637354 v2.0 04/26
Lenken "Ja" nedenfor tar deg til et nettsted som ikke tilhører Abbott Laboratories. Lenker til andre nettsteder er ikke under kontroll av Abbott Laboratories, og Abbott Laboratories er ikke ansvarlig for innholdet på slike nettsteder eller noen lenker på slike nettsteder. Abbott Laboratories gir disse lenkene til deg kun som en bekvemmelighet, og inkluderingen av en lenke innebærer ikke at Abbott Laboratories godkjenner nettstedet.
Vil du forlate denne siden?
Dette er et produktspesifikt nettsted kun beregnet for helsepersonell i Norge. Hvis du bor i et annet land, kontakt ditt lokale Abbott-kontor for å få riktig produktinformasjon for ditt land.
Tar deg til pasientsiden
Tar deg til helsepersonellsiden